All In Biotech

Drug Trial Radar · NCT05772520

The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis

A Randomized, Double-blinded, Placebo-controlled, Multicenter Phase 2 Study Evaluating the Efficacy and Safety of TLL018 in Participants With Moderate-to-severe Plaque Psoriasis

Last checked: Nov 19, 2026Latest source record: Jul 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

82

Actual

Start

Jan 19, 2023

Primary completion

Dec 1, 2024

Study completion Dec 23, 2024

Sponsor

Sponsor type
Industry
First posted
Mar 16, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2, multicenter, randomized, double-blinded, parallel dose group, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of 2 doses of TLL018 as therapy in approximately 90 participants with moderate-to-severe PP.

Conditions

  • Plaque Psoriasis

Interventions

  • TLL018 tabletsDrug

    oral tablets administered 20 mg BID and 40 mg BID for 12 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Participants Achieving PASI-75 (FAS)Time frame: Week12
  2. Proportion of Participants Achieving PASI 75 (PPS)Time frame: Week12

Locations

35 sites in 1 country. Site status is shown where the registry gives one.

  • Cahaba

    Birmingham, Alabama

  • Moy, Fincher, Chipps

    Beverly Hills, California

  • Metropolis Derm

    Los Angeles, California

  • Amicis Research Center

    Northridge, California

  • Integrative Skin

    Sacramento, California

  • Skin Surgical

    San Diego, California

  • Life Clinical Trials

    Coral Springs, Florida

  • Palm Beach

    DeLand, Florida

  • D&H Doral Research Center LLC

    Doral, Florida

  • Sweet Hope Research Specialty, Inc

    Hialeah, Florida

  • CNS - Jacksonville

    Jacksonville, Florida

  • CNS - Orlando SODO

    Jacksonville, Florida

  • Altus Research

    Lake Worth, Florida

  • Anchor Medical Research, LLC (Core Clinical Trials)

    Miami, Florida

  • Reserka Research

    Miami, Florida

  • ForCare Medical (CenExcel)

    Tampa, Florida

  • Integrated Clinical Trial Services, Inc

    Des Moines, Iowa

  • IMA Clinical Research

    Monroe, Louisiana

  • Lawrence Green

    Rockville, Maryland

  • Metro Boston

    Brighton, Massachusetts

  • Oakland Hills Dermatology

    Auburn Hills, Michigan

  • Revival Research Institute

    Troy, Michigan

  • Grekin Skin

    Warren, Michigan

  • Minnesota Clinical Study Center

    New Ulm, Minnesota

  • Mount Sinai

    New York, New York

  • Sadick Research Group

    New York, New York

  • Remington-Davis, Inc.

    Columbus, Ohio

  • DermDox

    Sugarloaf, Pennsylvania

  • CRCC

    Charleston, South Carolina

  • Dermatology Associates of Knoxville

    Knoxville, Tennessee

  • Derm Research

    Austin, Texas

  • Studies in Dermatology, LLC

    Cypress, Texas

  • Austin Institute for Clinical Research

    Pflugerville, Texas

  • Progressive Clinical Research Group, Inc.

    San Antonio, Texas

  • Acclaim

    Sugar Land, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.